New center key component of fundraising campaign, Mission Possible: The Dana-Farber Campaign to Conquer Cancer
Dana-Farber and state leaders dig in during the groundbreaking for the Yawkey Center for Cancer Care.
Dana-Farber Cancer Institute today celebrated the ceremonial
groundbreaking for the Yawkey Center for Cancer Care, a state-of-the-art
outpatient care and clinical research facility that will serve as the
model for cancer centers of the future.
"The need for expert cancer care is growing in our region and
nationally because our society is aging, treatments are becoming more
effective and intensive, and, fortunately, people with cancer are
surviving longer," said Edward J. Benz, Jr., MD, president at
Dana-Farber. "The new Yawkey Center for Cancer Care is the centerpiece
of Dana-Farber's response to this need for the best 21st Century cancer
care and for new modes of clinical research designed to bring better
treatments to patients more quickly and safely."
The groundbreaking drew a wide range of state and local public
officials, including U.S. Senator Edward M. Kennedy (D-MA),
Massachusetts Governor Deval L. Patrick, U.S. Representative Michael
Capuano (MA-08), Boston Mayor Thomas M. Menino, Massachusetts State
Representative Jeffrey Snchez, and Boston City Councilor Michael Ross,
and several former Red Sox players: Carl Yastrzemski, Johnny Pesky and
The Yawkey Center for Cancer Care will house many of Dana-Farber's
adult clinical services, as well as translational research space and
patient and family services. The 275,000-square-foot building, to be
constructed at 450 Brookline Avenue in the heart of Dana-Farber's
campus, will include 100 exam rooms, 150 infusion beds, and a welcoming
and patient-friendly front entrance for Dana-Farber. The building is
expected to be ready for occupancy in early 2011.
An artist's rendering of the Yawkey Center for Cancer Care
As the first new clinical building Dana-Farber has constructed in
more than 30 years, the center will enable Dana-Farber to address space
issues driven by the rapidly accelerating pace of cancer research and a
dramatic increase in the number of patients treated at Dana-Farber.
Between 2001 and 2006, outpatient visits and chemotherapy infusions at
Dana-Farber grew by more than 51 percent, from nearly 128,000 to more
than 194,000. The number of clinical trials available to Dana-Farber
patients increased more than 53 percent, from 409 trials to 629, during
the same period. Dana-Farber officials expect this growth to continue,
due in part to the aging of the U.S. population — cancer
disproportionately strikes people older than 60 — and increased survival
"The Yawkey Center for Cancer Care will provide Dana-Farber with a
new world-class facility in which to provide its world-class care and
research," said Larry Lucchino, who is co-chair of the Mission Possible
Campaign and President/CEO of the Boston Red Sox. "As a two-time cancer
survivor and a former Dana-Farber patient, I know firsthand how critical
it is to a cancer patient's physical and emotional well-being to
receive the most clinically advanced and compassionate care in a
The Yawkey Center for Cancer Care will serve patients of the
Dana-Farber/Brigham and Women's Cancer Center, Dana-Farber's
collaboration in adult oncology with Brigham and Women's Hospital, with
outpatient care provided at Dana-Farber and inpatient care at Brigham
and Women's Hospital. A similar collaboration defines Dana-Farber's
50-year relationship with Children's Hospital Boston for pediatric
cancer care (Dana-Farber/Children's Hospital Cancer Care).
The development of the Yawkey Center for Cancer Care is one of the key components of Dana-Farber's fundraising campaign, Mission Possible: The Dana-Farber Campaign to Conquer Cancer.
The campaign seeks to raise $1 billion to accelerate the pace of cancer
research, promote the translation of scientific advances into new
life-saving therapies, and expand Dana-Farber's ability to provide its
signature patient- and family-centered care.
The facility is named in honor of the Yawkey Foundation for its $30
million campaign gift — the largest overall gift in the foundation's
history — to Dana-Farber in April 2007 to support the facility's
construction. It also recognizes the longstanding relationship between
the late Tom and Jean Yawkey and Dana-Farber and the Jimmy Fund.
"Tom and Jean Yawkey were deeply devoted to supporting the
life-saving work of Dr. Sidney Farber and the Institute," said James
Healey, president and trustee of the Yawkey Foundation. "They both gave
generously of their resources and personal time to support the battle
against cancer. Today, the Trustees of the Yawkey Foundation take great
pleasure in celebrating this longstanding relationship between the
Yawkeys and Dana-Farber."
The histories of Dana-Farber and the Yawkey family are inextricably
linked. In 1953, the Yawkeys adopted the Jimmy Fund as the official
charity of the Boston Red Sox, which they owned from 1933-2002. The Red
Sox-Jimmy Fund partnership, which remains strong and fruitful to this
day, has generated millions of dollars in support for cancer care and
research at Dana-Farber and has helped to make contributing to the Jimmy
Fund a New England tradition.
"As much as the Yawkey Center for Cancer Care will benefit the
patients of Dana-Farber, it also will help cancer patients around the
world as the knowledge that is gained within the center exam rooms and
laboratories will be used to further research and care for all cancer
patients," said Josh Bekenstein, co-chair of the Mission Possible Campaign and a managing director of Bain Capital.
Zimmer Gunsul Frasca Architects LLP (ZGF), a national architecture,
planning and interior design firm headquartered in Portland, Ore., and
Miller Dyer Spears (MDS), a Boston-based architectural and planning
firm, will oversee the center's design and development. ZGF is the
design architect and MDS is the associate architect. Walsh Brothers,
Incorporated of Boston is the construction manager for the project.
Additional information about the campaign is available online at www.dana-farber.org/campaign.
About Dana-Farber Cancer Institute
Founded in 1947 by Sidney Farber, MD, the father of modern chemotherapy, Dana-Farber Cancer Institute (www.dana-farber.org)
is a principal teaching affiliate of Harvard Medical School, a founding
member of the Dana-Farber/Harvard Cancer Center, a National Cancer
Institute-designated comprehensive cancer center, and a federally
designated Center for AIDS Research.
About the Mission Possible Campaign
Mission Possible: The Dana-Farber Campaign to Conquer Cancer (www.dana-farber.org/campaign)
seeks to provide Dana-Farber scientists with the tools to further
uncover the genetic and molecular roots of cancer, and to turn that
knowledge into ever better therapies for people battling the disease.
The $1 billion campaign will support four critical areas: research and
care; technology; the Yawkey Center for Cancer Care; and the Jimmy Fund
and unrestricted funds, which will support the most pressing needs and
promising developments at Dana-Farber.